ArticleFrontiers in immunology2026

Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer.

Ran An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.